Author

F. Walker

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Ecology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Gilani· 1 shared A. Green· 1 shared A. Pierce· 1 shared A. W. Burgess· 1 shared B. Hoeglinger· 1 shared C. A. Bruehl· 1 shared D. Gerhard· 1 shared D. Wang· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Gilani

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The neonicotinoid acetamiprid is highly toxic to wild non-target insects

J. E. Sedlmeier, I. Grass, P. Bendalam, B. Hoeglinger, F. Walker, D. Gerhard, H.-P. Piepho, C. A. Bruehl, G. Petschenka

This study shows that the neonicotinoid acetamiprid is highly toxic to plant bugs, with effects up to 10,000 times greater than on honeybees and sex-specific differences in sensitivity.

bioRxiv · Apr 11, 2024 · PreprintEcology

Dual Drug Targeting to Kill Colon Cancer Cells

A. W. Burgess, M. C. Faux, S. P. Corona, J. Weinstock, G. Lessene, F. Walker

The paper investigates the effectiveness of dual drug combinations in killing colon cancer cells and identifies a viable oral treatment for xenograft models.

bioRxiv · Feb 28, 2021 · PreprintCancer Biology

Super elongation complex as a targetable dependency in diffuse midline glioma

N. A. Dahl, E. Danis, I. Balakrishnan, D. Wang, A. Pierce, F. Walker, A. Gilani, N. Serkova, K. Madhaven, S. Fosmire, A. Green, N. K. Foreman, S. Venkataraman, R. Vibhakar

This study identifies AFF4 as a therapeutic target in diffuse midline glioma by showing CDK9 inhibitors inhibit the super elongation complex and induce anti-tumor effects.

bioRxiv · Jan 22, 2020Cancer Biology